Startseite Visible-light mediated regioselective (phenylsulfonyl)difluoromethylation of fused imidazoles with iododifluoromethyl phenyl sulfone
Artikel Open Access

Visible-light mediated regioselective (phenylsulfonyl)difluoromethylation of fused imidazoles with iododifluoromethyl phenyl sulfone

  • Guojie Yin , Mei Zhu und Weijun Fu EMAIL logo
Veröffentlicht/Copyright: 27. Juni 2017

Abstract

A visible-light catalyzed direct and regioselective (phenylsulfonyl)difluoromethylation of imidazo[1,2-a]pyridines and benzo[d]-imidazo [2,1-b]thiazoles with readily available PhSO2CF2I under mild conditions was developed. This synthetic methodology enables the introduction of a CF2SO2Ph group in an efficient and regioselective reaction through C-H bond functionalization with a broad substrate scope in good to excellent yields.

Introduction

The difluoromethyl moiety is one of the key structural units found in pharmaceuticals, agrochemicals and functional materials mainly due to its excellent binding affinity, enhancement of membrane permeability, and high bioavailability [1]. Consequently, extensive efforts have been devoted to the development of methods for selective introduction of difluoromethyl group onto a particular position [2], [3]. Among the various sources of difluorinated moieties, a (phenylsulfonyl)difluoromethyl group (PhSO2CF2) is appealing because of its versatile functionality that can be further modified into other functionalized fluoroalkyl groups [4], [5]. Miscellaneous methods for the incorporation of PhSO2CF2 motifs have been extensively investigated over the years. The traditional methods for the synthesis of PhSO2CF2-containing molecules typically involve nucleophilic addition, coupling of boronic acids and radical addition [6], [7], [8], [9]. Alternatively, the direct (phenylsulfonyl)difluoromethylation of C-H bonds appears to be more economical and practical synthetic approach towards PhSO2CF2-containing heteroarenes. In 2014, Wang and co-workers reported a visible-light photoredox-catalyzed (phenylsulfonyl)difluoromethylation of electron-rich N-, O-, and S-containing heteroarenes with PhSO2CF2I [10]. However, these examples are mainly concentrated on pyrroles and indoles. As far as we know, there has been no report on the introduction of a PhSO2CF2 group at the imidazo[1,2-a]pyridine system.

Imidazo[1,2-a]pyridines are an important class of heterocycles with unique chemical and biological properties. This fused heterocycle is found in many bioactive natural products, pharmaceuticals and agrochemicals, and many of them exhibit potent biological activities, such as antiviral, antimicrobial, antitumor and anti-inflammatory properties [11], [12], [13]. Attention has been paid to the development of efficient methods for the synthesis of imidazopyridine derivatives [14], [15]. In this regard, the functionalization of imidazo[1,2-a]pyridine derivatives through transition-metal-catalyzed coupling or the electrophile and radical addition reactions at the 3-position have made significant progress [16]. Various functionalized atoms (C, S, N and Se) have been successfully introduced into the 3-position of imidazo[1,2-a]pyridines [17], [18], [19], [20], [21], [22], [23], [24]. Recently, we also developed a visible-light-induced radical pathway to introduce a trifluoroethyl group into the imidazo[1,2-a]pyridine core at the 3-position [25]. As a continuation of our interest in methodology for the synthesis of fluorinated heterocycles [26], [27], [28], we wished to introduce other versatile building blocks into the imidazo[1,2-a]pyridine structure with the aim of synthesizing various 3-functionalized imidazo[1,2-a]pyridines in a radical fashion. We focused our attention on 3-PhSO2CF2-containing imidazo[1,2-a]pyridine architectures by visible-light photoredox catalysis.

Results and discussion

Our initial investigation focused on the reaction of 2-phenylimidazo[1,2-a]pyridine (1a) and PhSO2CF2I (1.5 equiv) under the catalysis of fac-Ir(ppy)3 (2 mol%) in DMSO (Scheme 1). The C-3 regioselective (phenylsulfonyl)difluoromethylation reaction proceed smoothly to give the desired product 2a in 68% yield. When Ru(bpy)3(PF6)2 was used instead of fac-Ir(ppy)3, the yield of this reaction was only 40%, and eosin Y was totally inactive. After screening a series of bases, such as Na2CO3, K2CO3 and KOAc using fac-Ir(ppy)3 as the photocatalyst, K2CO3 was found to be the best choice and gave 86% yield. Other solvents such as DMF, DCM and acetonitrile were also tested for the (phenylsulfonyl)difluoromethylation reaction of 1a at room temperature, but they all were less efficient compared with DMSO. Moreover, the reaction was completely inhibited in the absence of the photocatalyst or in the dark. Thus, fac-Ir(ppy)3 (2 mol%), PhSO2CF2I (1.5 equiv), and K2CO3 (1.5 equiv) in DMSO under 5 W blue LED irradiation have been defined as the optimized reaction conditions.

Scheme 1 Synthesis of PhSO2CF2-containing imidazo[1,2-a]pyridines.
Scheme 1

Synthesis of PhSO2CF2-containing imidazo[1,2-a]pyridines.

With the optimum conditions in hand, we investigated the scope of this visible-light mediated (phenylsulfonyl)difluoromethylation with diverse imidazopyridines and the results are summarized in Scheme 1. It was found that a variety of imidazo[1,2-a]pyridines can be successfully (phenylsulfonyl)difluoromethylated at the C3-position with high selectivity to the desired products in moderate to good yields. We first examined the substituent effect at the 2-arylimidazo[1,2-a]pyridines. In general, the reactions of substrates containing electron-donating groups tend to give the desired products in slightly higher yields (85%–91%) than compound 1m substituted with an electron-withdrawing 5-fluoro atom. Aryl and alkyl substituted substrates are well tolerated in this transformation.

Benzo[d]-imidazo[2,1-b]thiazole derivatives were also successfully applied in the reaction, and the desired products 4a,b were prepared in excellent yield (Scheme 2).

Scheme 2 Regioselective (phenylsulfonyl)difluoromethylation of benzo[d]-imidazo[2,1-b]thiazoles.
Scheme 2

Regioselective (phenylsulfonyl)difluoromethylation of benzo[d]-imidazo[2,1-b]thiazoles.

As already mentioned, the CF2SO2Ph group is an important motif which can be converted into CF2H group. The product 2a in DMF/HOAc/NaOAc, in the presence of Mg, was converted into difluoromethylated imidazo[1,2-a]pyridine 5 in 77% yield (Scheme 3).

Scheme 3 Desulfonylation of 2a.
Scheme 3

Desulfonylation of 2a.

Conclusions

We described an efficient and general method for the synthesis of PhSO2CF2-containing imidazo[1,2-a]pyridines and benzo[d]-imidazo[2,1-b]thiazoles using a visible-light-mediated reaction of PhSO2CF2I with imidazoheterocycles. The reaction of imidazopyridines is regioselective.

Experimental

All reactions were performed in a 20-mL tube equipped with a rubber septum at room temperature. Photo-irradiation was carried out with a 5 W blue LED. Solvents were purified or dried in a standard manner. 1H NMR (500 MHz), 13C NMR (125 MHz) and 19F NMR (470 MHz) spectra were measured in CDCl3. HR-MS analyses were recorded using ESI technique.

General procedure for the synthesis of PhSO2CF2-containing imidazo[1,2-a]pyridines 2a-o and benzo[d]-imidazo[2,1-b]thiazoles 4a,b

A mixture of imidazo[1,2-a]pyridine 1 or benzo[d]-imidazo[2,1-b]thiazole 3 (0.30 mmol), ICF2SO2Ph (0.45 mmol) and K2CO3 (0.45 mmol) in 3.0 mL of DMSO was treated with fac-Ir(ppy)3 (0.006 mmol, 2.0 mol%) under N2 atmosphere. The mixture was stirred at room temperature under 5 W blue LED irradiation for 24 h and then quenched with EtOAc and brine. The aqueous layer was extracted with EtOAc. The combined extracts were dried over MgSO4, filtered and concentrated. The residue was purified by silica gel chromatography eluting with petroleum ether/ethyl acetate (5:1) as the eluent to give pure product 2.

3-(Difluoro(phenylsulfonyl)methyl)-2-phenylimidazo[1,2-a]pyridine (2a)

White solid; mp 135–137°C; yield 86%; 1H NMR: δ 8.71 (d, J=7.5 Hz, 1H), 7.99 (d, J=7.5 Hz, 2H), 7.73–7.78 (m, 4H), 7.60–7.64 (m, 2H), 7.41–7.46 (m, 4H), 7.01–7.04 (m, 1H); 13C NMR: δ 152.1, 147.5, 135.6, 133.3, 132.8, 130.7, 129.7, 129.5, 128.8, 127.9, 127.7, 127.5 (t, J=5.0 Hz), 120.4 (t, J=285 Hz), 117.8, 113.7, 106.6 (t, J=29 Hz); 19F NMR: δ −97.3 (s, 2 F). ESI-HRMS. Calcd for C20H15F2N2O2S, [M+H]+: m/z 385.0822. Found: m/z 385.0815.

3-(Difluoro(phenylsulfonyl)methyl)-2-(p-tolyl)imidazo[1,2-a]pyridine (2b)

White solid; mp 122–124°C; yield 90%; 1H NMR: δ 8.70 (d, J=7.0 Hz, 1H), 8.00 (d, J=7.5 Hz, 2H), 7.74–7.80 (m, 2H), 7.61–7.64 (m, 4H), 7.43 (t, J=7.5 Hz, 1H), 7.23 (d, J=8.0 Hz, 2H), 7.02 (d, J=7.0 Hz, 1H), 2.43(s, 3H); 13C NMR: δ 152.2, 147.4, 138.7, 135.5, 132.9, 130.7, 130.3, 129.5, 129.4, 128.6, 127.6, 127.5 (t, J=5.5 Hz), 120.5 (t, J=285.0 Hz), 117.7, 113.6, 106.3 (t, J=29 Hz), 21.4; 19F NMR: δ −97.3 (s, 2 F). ESI-HRMS. Calcd for C21H17F2N2O2S, [M+H]+: m/z 399.0979. Found: m/z 399.0987.

3-(Difluoro(phenylsulfonyl)methyl)-2-(m-tolyl)imidazo[1,2-a]pyridine (2c)

White solid; mp 117–118°C; yield 85%; 1H NMR: δ 8.69 (d, J=7.0 Hz, 1H), 7.95 (d, J=8.0 Hz, 2H), 7.72–7.78 (m, 2H), 7.58–7.61 (m, 2H), 7.50 (d, J=7.5 Hz, 1H), 7.46 (s, 1H), 7.40–7.44 (m, 1H), 7.28 (t, J=8.0 Hz, 1H), 7.21 (d, J=7.5 Hz, 1H), 6.99–7.02 (m, 1H), 2.40 (s, 3H); 13C NMR: δ 152.2, 147.4, 137.4, 135.5, 133.3, 132.9, 130.6, 130.3, 129.6, 127.7, 127.5 (t, J=5.0 Hz), 126.8, 120.4 (t, J=285.0 Hz), 117.8, 113.7, 106.6 (t, J=29.3 Hz), 21.4; 19F NMR: δ −97.2 (s, 2 F). ESI-HRMS. Calcd for C21H17F2N2O2S, [M+H]+: m/z 399.0979. Found: m/z 399.0974.

3-(Difluoro(phenylsulfonyl)methyl)-2-(4-methoxyphenyl)imidazo[1,2-a]pyridine (2d)

White solid; mp 115–117°C; yield 91%; 1H NMR: δ 8.67 (d, J=7.0 Hz, 1H), 7.98 (d, J=7.5 Hz, 2H), 7.71–7.78 (m, 2H), 7.67 (d, J=8.0 Hz, 2H), 7.61 (t, J=8.0 Hz, 2H), 7.40 (d, J=7.0 Hz, 1H), 6.98 (t, J=7.0 Hz, 1H), 6.93 (d, J=8.0 Hz, 2H), 3.86 (s, 3H); 13C NMR: δ 160.2, 152.0, 147.4, 135.5, 132.9, 131.0, 130.7, 129.5, 127.6, 127.5 (t, J=5.0 Hz), 120.5 (t, J=285 Hz), 117.7, 113.6, 113.4, 106.1 (t, J=29 Hz), 55.3; 19F NMR: δ −97.5 (s, 2 F). ESI-HRMS. Calcd for C21H17F2N2O3S, [M+H]+: m/z 415.0923. Found: m/z 415.0916.

2-(4-Chlorophenyl)-3-(difluoro(phenylsulfonyl)methyl)imidazo[1,2-a]pyridine (2e)

White solid ; mp 131–133°C; yield 73%; 1H NMR: δ 8.67 (d, J=7.0 Hz, 1H), 7.99 (d, J=7.5 Hz, 2H), 7.76 (d, J=7.5 Hz, 1H), 7.69–7.73 (m, 3H), 7.61 (t, J=8.0 Hz, 2H), 7.38–7.43 (m, 3H), 7.00 (t, J=7.0 Hz, 1H); 13C NMR: δ, 150.9, 147.5, 135.6, 135.1, 132.8, 131.8, 131.0, 130.7, 129.5, 128.1, 127.8, 127.5 (t, J=8.8 Hz), 120.3 (t, J=285 Hz), 117.8, 113.9, 106.8 (t, J=32 Hz); 19F NMR: δ −97.4 (s, 2 F). ESI-HRMS. Calcd for C20H14ClF2N2O2S, [M+H]+: m/z 419.0432. Found: m/z 419.0421.

2-(4-Bromophenyl)-3-(difluoro(phenylsulfonyl)methyl)imidazo[1,2-a]pyridine (2f)

White solid; mp 139–140°C; yield 70%; 1H NMR: δ 8.67 (d, J=7.0 Hz, 1H), 8.00 (d, J=7.5 Hz, 2H), 7.72–7.80 (m, 2H), 7.61–76.5 (m, 4H), 7.54 (d, J=7.5 Hz, 2H), 7.44 (t, J=7.5 Hz, 1H), 7.02 (d, J=7.0 Hz, 1H); 13C NMR: δ 150.9, 147.5, 135.7, 132.7, 132.2, 131.5, 131.3, 130.7, 129.6, 127.9, 127.5 (t, J=9.1 Hz), 123.4, 120.3 (t, J=285 Hz), 117.8, 113.9, 106.7 (t, J=29 Hz); 19F NMR: δ −97.4 (s, 2 F). ESI-HRMS. Calcd for C20H14BrF2N2O2S, [M+H]+: m/z 462.9927. Found: m/z 462.9938.

2-(3-Bromophenyl)-3-(difluoro(phenylsulfonyl)methyl)imidazo[1,2-a]pyridine (2g)

White solid; mp 122–124°C; yield 68%; 1H NMR: δ 8.70 (d, J=7.0 Hz, 1H), 7.96 (d, J=7.5 Hz, 2H), 7.79–7.82 (m, 2H), 7.75 (d, J=8.0 Hz, 1H), 7.69 (d, J=7.5 Hz, 1H), 7.60–7.64 (m, 2H), 7.53–7.55 (m, 1H), 7.44–7.48 (m, 1H), 7.27–7.0 (m, 1H), 7.03–7.07 (m, 1H); 13C NMR: δ, 150.2, 147.4, 135.8, 135.1, 132.6, 132.5, 131.8, 130.7, 129.6, 129.4, 128.4, 128.0, 127.5 (t, J=5.0 Hz), 121.9, 120.2 (t, J=285 Hz), 117.9, 114.1, 107.0 (t, J=29 Hz); 19F NMR: δ −97.5 (s, 2 F). ESI-HRMS. Calcd for [M+H]+ C20H14BrF2N2O2S, [M+H]+: m/z 462.9927. Found: m/z 462.9920.

3-(Difluoro(phenylsulfonyl)methyl)-2-(4-fluorophenyl)imidazo[1,2-a]pyridine (2h)

White solid; mp 102–104°C; yield 73%; 1H NMR: δ 8.67 (d, J=7.0 Hz, 1H), 7.98 (d, J=8.0 Hz, 2H), 7.71–7.77 (m, 4H), 7.60 (t, J=8.0 Hz, 2H), 7.41 (t, J=7.0 Hz, 1H), 7.09 (t, J=7.5 Hz, 2H), 6.99 (d, J=7.5 Hz, 1H); 13C NMR: δ 163.4 (d, J=247 Hz), 151.1, 147.4, 135.6, 132.9, 131.6 (d, J=8.3 Hz), 130.7, 129.5, 129.4, 127.8, 127.5 (t, J=6.0 Hz), 120.4 (t, J=285 Hz), 117.8, 114.9 (d, J=21 Hz), 113.8, 106.6 (t, J=29 Hz); 19F NMR: δ −97.4 (s, 2 F), −112.7(s, 1 F). ESI-HRMS. Calcd for C20H14F3N2O2S, [M+H]+: m/z 403.0728. Found: m/z 403.0730.

4-(3-(Difluoro(phenylsulfonyl)methyl)imidazo[1,2-a]pyridin-2-yl)benzonitrile (2i)

White solid; mp 139–141°C; yield 62%; 1H NMR: δ 8.68 (d, J=7.0 Hz, 1H), 8.02 (d, J=7.5 Hz, 2H), 7.92 (d, J=8.0 Hz, 2H), 7.79 (t, J=8.0 Hz, 1H), 7.71–7.77 (m, 3H), 7.64 (t, J=7.5 Hz, 2H), 7.45 (t, J=7.5 Hz, 1H), 7.04 (t, J=7.0 Hz, 1H); 13C NMR: δ 149.9, 147.7, 137.9, 135.8, 132.6, 131.7, 130.8, 130.5, 129.6, 128.2, 127.5 (t, J=4.8 Hz), 120.2 (t, J=285 Hz), 118.7, 118.1, 114.2, 112.7, 107.3 (t, J=29 Hz); 19F NMR: δ −97.3 (s, 2 F). ESI-HRMS. Calcd for C21H14F2N3O2S, [M+H]+: m/z 410.0775. Found: m/z 410.0768.

2-([Biphenyl]-4-yl)-3-(difluoro(phenylsulfonyl)methyl)imidazo[1,2-a]pyridine (2j)

White solid; mp 143–145°C; yield 81%; 1H NMR: δ 8.69 (d, J=7.0 Hz, 1H), 8.00 (d, J=7.5 Hz, 2H), 7.81 (d, J=8.0 Hz, 2H), 7.74 (d, J=8.0 Hz, 2H), 7.64–7.67 (m, 4H), 7.59 (d, J=7.5 Hz, 2H), 7.46 (t, J=7.5 Hz, 2H), 7.41 (t, J=8.0 Hz, 1H), 7.6 (t, J=7.5 Hz, 1H), 7.00 (d, J=7.0 Hz, 1H); 13C NMR: δ 151.8, 147.5, 141.5, 140.7, 135.6, 132.8, 132.2, 130.7, 130.1, 129.5, 128.8, 127.8, 127.6 (t, J=8.9 Hz), 127.2, 126.6, 120.5 (t, J=285 Hz), 117.8, 113.8, 106.6 (t, J=29 Hz); 19F NMR: δ −97.2 (s, 2 F). ESI-HRMS. Calcd for C26H19F2N2O2S, [M+H]+: m/z 461.1135. Found: m/z 461.1124.

3-(Difluoro(phenylsulfonyl)methyl)-7-methyl-2-phenylimidazo[1,2-a]pyridine (2k)

White solid; mp 132–133°C; yield 75%; 1H NMR: δ 8.55 (d, J=7.0 Hz, 1H), 7.95 (d, J=7.5 Hz, 2H), 7.75 (t, J=7.5 Hz, 1H), 7.65–7.67 (m, 2H), 7.59 (t, J=7.5 Hz, 2H), 7.47 (s, 1H), 7.37–7.39 (m, 3H), 6.83–6.85 (m, 1H), 2.47 (s, 3H); 13C NMR: δ 152.1, 147.9, 139.1, 135.5, 132.9, 130.6, 129.6, 129.5, 128.7, 127.8, 126.6 (t, J=4.9 Hz), 120.4 (t, J=289 Hz), 116.3, 116.2, 106.9 (t, J=29 Hz), 21.4; 19F NMR: δ −97.2 (s, 2 F). ESI-HRMS. Calcd for C21H17F2N2O2S, [M+H]+: m/z 399.0979. Found: m/z 399.0984.

3-(Difluoro(phenylsulfonyl)methyl)-6-methyl-2-phenylimidazo[1,2-a]pyridine (2l)

White solid; mp 113–115°C; yield 81%; 1H NMR: δ 8.45 (s, 1H), 7.98 (d, J=8.0 Hz, 2H), 7.78 (t, J=7.5 Hz, 1H), 7.60–7.68 (m, 5H), 7.39–7.41 (m, 3H), 7.28 (d, J=7.5 Hz, 1H), 2.46 (s, 3H); 13C NMR: δ 151.8, 146.5, 135.5, 133.4, 132.9, 130.8, 130.7, 129.6, 129.5, 128.7, 127.8, 125.1 (t, J=8.9Hz), 123.6, 120.4 (t, J=285 Hz), 117.0, 106.3 (t, J=29 Hz), 18.6; 19F NMR: δ −97.2 (s, 2 F). ESI-HRMS. Calcd for C21H17F2N2O2S, [M+H]+: m/z 399.0979. Found: m/z 399.0968.

3-(Difluoro(phenylsulfonyl)methyl)-6-fluoro-2-phenylimidazo[1,2-a]pyridine (2m)

White solid; mp 122–124°C; yield 63%; 1H NMR: δ 8.66 (s, 1H), 7.74–7.81 (m, 4H), 7.62–7.66 (m, 4H), 7.40–7.45 (m, 3H), 7.35 (t, J=8.0 Hz, 1H); 13C NMR: δ 153.5 (d, J=237 Hz), 152.9, 145.1, 135.7, 132.9, 132.6, 130.7, 129.6, 128.9, 127.9, 120.1 (t, J=285.0 Hz), 119.7 (d, J=25 Hz), 118.1 (d, J=8.3 Hz), 114.8 (d, J=43 Hz), 108.1 (t, J=30 Hz); 19F NMR: δ −98.1 (s, 2 F), −137.2 (s, 1 F). ESI-HRMS. Calcd for C20H14F3N2O2S, [M+H]+: m/z 403.0728. Found: m/z 403.0718.

3-(Difluoro(phenylsulfonyl)methyl)-2-(naphthalen-2-yl)imidazo[1,2-a]pyridine (2n)

White solid; mp 120–121°C; yield 76%; 1H NMR: δ 8.75 (d, J=7.0 Hz, 1H), 8.24 (s, 1H), 8.00 (d, J=8.0 Hz, 2H), 7.88–7.95 (m, 4H), 7.74–7.81 (m, 2H), 7.54–7.61 (m, 4H), 7.47 (t, J=8.0 Hz, 1H), 7.05 (t, J=7.0 Hz, 1H); 13C NMR: δ 152.1, 147.6, 135.6, 133.4, 132.9, 132.8, 130.7, 129.5, 128.6, 127.8, 127.7, 127.6, 127.4, 127.2, 126.5, 126.1, 120.5 (t, J=289 Hz), 117.8, 113.8, 106.9 (t, J=29 Hz); 19F NMR: δ −97.2 (s, 2 F). ESI-HRMS. Calcd for C24H17F2N2O2S, [M+H]+: m/z 435.0979. Found: m/z 435.0971.

3-(Difluoro(phenylsulfonyl)methyl)-2-methylimidazo[1,2-a]pyridine (2o)

White solid; mp 104–105°C; yield 88%; 1H NMR: δ 8.65 (d, J=7.5 Hz, 1H), 7.97 (d, J=8.0 Hz, 2H), 7.65(d, J=8.0 Hz, 2H), 7.58 (d, J=8.0 Hz, 1H), 7.41–7.44 (m, 1H), 7.23–7.20 (m, 1H), 6.87–6.85 (m, 1H), 2.48 (s, 3H); 13C NMR: δ 149.2, 146.7, 135.7, 132.4, 130.7, 129.6, 128.3, 126.7 (t, J=5.4 Hz), 120.3 (t, J=284 Hz), 116.9, 113.8, 107.1 (t, J=30 Hz), 14.8; 19F NMR: δ −100.1 (s, 2 F). ESI-HRMS. Calcd for C15H13F2N2O2S, [M+H]+: m/z 323.0661. Found: m/z 323.0665.

3-(Difluoro(phenylsulfonyl)methyl)-2-phenylbenzo[d]imidazo[2,1-b]thiazole (4a)

White solid; mp 173–175°C; yield 87%; 1H NMR: δ 8.24 (d, J=7.5 Hz, 1H), 7.95 (d, J=7.5 Hz, 2H), 7.73–7.76 (m, 2H), 7.52–7.62 (m, 5H), 7.43 (t, J=7.5 Hz, 1H), 7.35–7.38 (m, 3H); 13C NMR: δ 154.3, 152.7, 135.6, 133.2, 132.9, 132.7, 130.7, 129.9, 129.7, 129.5, 128.7, 127.7, 126.5, 125.6, 124.0, 120.1 (t, J=285 Hz), 111.7 (t, J=8.3 Hz), 109.9 (t, J=31.0 Hz); 19F NMR: δ −92.4. ESI-HRMS. Calcd for C22H15F2N2O2S2, [M+H]+: m/z 441.0543. Found: m/z 441.0548.

7-Chloro-3-(difluoro(phenylsulfonyl)methyl)-2-phenylbenzo[d]imidazo[2,1-b]thiazole (4b)

White solid; mp 158–160°C; yield 84%; 1H NMR: δ 8.16 (d, J=8.0 Hz, 1H), 7.94 (d, J=7.5 Hz, 2H), 7.64 (t, J=7.5 Hz, 1H), 7.35 (s, 1H), 7.59–7.65 (m, 4H), 7.54 (d, J=7.5 Hz, 1H), 7.33–7.38 (m, 3H); 13C NMR: δ 154.4, 152.3, 135.7, 133.0, 132.6, 131.5, 131.4, 130.7, 129.7, 129.6, 129.5, 128.9, 127.8, 126.9, 123.6, 120.0 (t, J=285 Hz), 117.8 (t, J=8.5 Hz), 110.0 (t, J=31 Hz); 19F NMR: δ −92.8. ESI-HRMS. Calcd for C22H14ClF2N2O2S2, [M+H]+: m/z 475.0153. Found: m/z 475.0167.

Desulfonylation of compound 2a to 3-(difluoromethyl)-2-phenylimidazo[1,2-a]pyridine (5)

A mixture in a 10-mL flask containing compound 2a (77 mg, 0.2 mmol), DMF (2 mL), a buffer solution of HOAc/NaOAc (1:1, 8 mol/L, 2 mL) and magnesium turnings (96 mg, 4 mmol) was stirred at room temperature for 6 h and then quenched with water. The mixture was extracted with Et2O, and the extract was dried over MgSO4, filtered and concentrated. The residue was purified by silica gel chromatography eluting with petroleum ether/ethyl acetate (10:1) to furnish pure product 5: White solid; mp 105–107°C; yield 77%; 1H NMR: δ 8.14 (d, J=7.0 Hz, 1H), 7.96–7.00 (m, 2H), 7.88 (s, 1H), 7.67 (d, J=8.0 Hz, 1H), 7.46 (t, J=8.0 Hz, 2H), 7.34–7.37 (m, 1H), 7.18–7.21 (m, 1H), 6.80 (dt, J1=7.0 Hz, J2=1.0 Hz, 1H); 13C NMR: δ 147.6, 146.6, 133.6, 129.8, 128.7, 128.1, 127.9, 125.4, 124.3 (t, J=5.5 Hz), 113.5, 111.9 (t, J=30 Hz), 111.5 (t, J=246 Hz); 19F NMR: δ −98.4. ESI-HRMS. Calcd for C14H11F2N2, [M+H]+: m/z 245.0885. Found: m/z 245.0891.

Acknowledgments

This research was supported by the Program for Innovative Research at the University of Henan Province (14IRTSTHN008) and Aid Project for the Leading Young Teachers in Henan Provincial Institutions of Higher Education of China (2014GGJS-113).

References

[1] Meanwell, N. A. Synopsis of some recent tactical application of bioisosteres in drug design. J. Med. Chem.2011, 54, 2529–2591.10.1021/jm1013693Suche in Google Scholar PubMed

[2] Belhomme, M.-C.; Besset, T.; Poisson, T.; Pannecoucke, X. Recent progress toward the introduction of functionalized difluoromethylated building blocks onto C(sp2) and C(sp) centers. Chem. Eur. J.2015, 21, 12836–12865.10.1002/chem.201501475Suche in Google Scholar PubMed

[3] Barata-Vallejo, S.; Bonesi, S. M.; Postigo, A. Photocatalytic fluoroalkylation reactions of organic compounds. Org. Biomol. Chem.2015, 13, 11153–11183.10.1039/C5OB01486GSuche in Google Scholar

[4] Surapanich, N.; Kuhakarn, C.; Pohmakotr, M.; Reutrakul, V. Palladium-mediated heck-typereactions of [(bromodifluoromethyl)-sulfonyl]benzene: synthesis of α-alkenyl- and α-heteroaryl-substituted α,α- difluoromethyl phenyl sulfones. Eur. J. Org. Chem.2012, 2012, 5943–5952.10.1002/ejoc.201200613Suche in Google Scholar

[5] Li, X.; Zhao, J.; Hu, M.; Chen, D.; Ni, C.; Wang, L.; Hu, J. Copper-mediated aerobic (phenylsulfonyl)difluoromethylation of arylboronic acids with difluoromethyl phenyl sulfone. Chem. Commun.2016, 52, 3657–3660.10.1039/C5CC10550ASuche in Google Scholar

[6] Prakash, G. K. S.; Hu, J. Selective fluoroalkylations with fluorinated sulfones, sulfoxides, and sulfides. Acc. Chem. Res.2007, 40, 921–930.10.1021/ar700149sSuche in Google Scholar PubMed

[7] Ni, C.; Hu, J. Selective nucleophilic fluoroalkylations facilitated by removable activation groups. Synlett.2011, 6, 770–782.10.1055/s-0030-1259906Suche in Google Scholar

[8] Xiao, P.; Rong, J.; Ni, C.; Guo, J.; Li, X.; Chen, D.; Hu, J. Radical (phenylsulfonyl)difluoromethylation of isocyanides with PhSO2CF2H under transition-metal-free conditions. Org. Lett.2016, 18, 5912–5915.10.1021/acs.orglett.6b03013Suche in Google Scholar PubMed

[9] Wang, X.; Liu, G.; Xu, X.-H.; Shibata, N.; Tokunaga, E.; Shibata, N. S-((phenylsulfonyl)difluoromethyl)thiophenium salts: carbon-selective electrophilic difluoromethylation of β-ketoesters, β-diketones, and dicyanoalkylidenes. Angew. Chem., Int. Ed.,2014, 53, 1827–1831.10.1002/anie.201309875Suche in Google Scholar PubMed

[10] Su, Y.-M.; Hou, Y.; Yin, F.; Xu, Y.-M.; Li, Y.; Zheng, X.; Wang, X.-S. Visible light-mediated C−H difluoromethylation of electron-rich heteroarenes. Org. Lett.2014, 16, 2958–2961.10.1021/ol501094zSuche in Google Scholar PubMed

[11] Baviskar, A. T.; Madaan, C.; Preet, R.; Mohapatra, P.; Jain, V.; Agarwal, A.; Guchhait, S. K.; Kundu, C. N.; Banerjee, U. C.; Bharatam, P. V. N-Fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase. J. Med. Chem.2011, 54, 5013–5030.10.1021/jm200235uSuche in Google Scholar PubMed

[12] Gladysz, R.; Adriaenssens, Y.; De Winter, H.; Joossens, J.; Lambeir, A.-M.; Augustyns, K.; Van der Veken, P. Discovery and SAR of novel and selective inhibitors of urokinase plasminogen activator (uPA) with an imidazo[1,2-a]pyridine scaffold. J. Med. Chem.2015, 58, 9238–9257.10.1021/acs.jmedchem.5b01171Suche in Google Scholar PubMed

[13] Enguehard-Gueiffier, C.; Gueiffier, A. Recent progress in the pharmacology of imidazo[1,2-a]pyridines. Mini-Rev. Med. Chem.2007, 7, 888–899.10.2174/138955707781662645Suche in Google Scholar PubMed

[14] Bagdi, A. K.;Santra, S.; Monir, K.; Hajra, A. Synthesis of imidazo[1,2-a]pyridines: a decade update. Chem. Commun.2015, 51, 1555–1575.10.1039/C4CC08495KSuche in Google Scholar PubMed

[15] Pericherla, K.; Kaswan, P.; Pandey, K.; Kumar, A. Recent developments in the synthesis of imidazo[1,2-a]pyridines. Synthesis2015, 47, 887–912.10.1055/s-0034-1380182Suche in Google Scholar

[16] Bagdi, A. K.; Hajra, A. Design, synthesis, and functionalization of imidazoheterocycles. Chem. Rec.2016, 16, 1868–1885.10.1002/tcr.201600057Suche in Google Scholar PubMed

[17] Monir, K.; Bagdi, A. K.; Ghosh, M.; Hajra, A. Regioselective oxidative trifluoromethylation of imidazoheterocycles via C(sp2)−H Bond functionalization. J. Org. Chem.2015, 80, 1332–1337.10.1021/jo502928eSuche in Google Scholar PubMed

[18] Liu, P.; Guo, Y.; Gu, W.; Shen, Z.; Sun, P. Regioselective fluorination of imidazo[1,2-a]pyridines with selectfluor in aqueous condition. J. Org. Chem.2015, 80, 11559–11565.10.1021/acs.joc.5b01961Suche in Google Scholar PubMed

[19] Yang, D.-S.; Yan, K.-L.; Wei, W.; Li, G.-Q.; Lu, S.-L.; Zhao, C.-X.; Tian, L.-J.; Wang, H. Catalyst-free regioselective C-3 thiocyanation of imidazopyridines. J. Org. Chem.2015, 80, 11073–11079.10.1021/acs.joc.5b01637Suche in Google Scholar PubMed

[20] Mishra, S.; Mondal, P.; Ghosh, M.; Mondal, S.; Hajra, A. Copper-catalyzed C–H ethoxycarbonyldifluoromethylation of imidazoheterocycles. Org. Biomol. Chem.2016, 14, 1432–1436.10.1039/C5OB02363GSuche in Google Scholar PubMed

[21] Wang, Y.; Frett, B.; McConnella, N.; Li, H.-Y. Metal-free, efficient hydrazination of imidazo[1,2-a]pyridine with diethyl azodicarboxylate in neutral media. Org. Biomol. Chem.2015, 13, 2958–2964.10.1039/C4OB02284JSuche in Google Scholar PubMed PubMed Central

[22] Lu, S.; Zhu, X.; Li, K.; Guo, Y.-J.; Wang, M.-D.; Zhao, X.-M.; Hao, X.-Q.; Song, M.-P. Reactivity ofp-toluenesulfonylmethyl isocyanide: iron-involved C–H tosylmethylation of imidazopyridines in nontoxic media. J. Org. Chem.2016, 81, 8370–8377.10.1021/acs.joc.6b01552Suche in Google Scholar PubMed

[23] Ji, X.-M.; Wei, L.; Chen, F.; Tang, R.-Y. Direct trifluoromethylation of imidazoheterocycles in a recyclable medium at room temperature. RSC Adv.2015, 5, 29766–29773.10.1039/C5RA02888DSuche in Google Scholar

[24] Wu, Y.; Zhang, H.-R.; Ji, R.-X.; Lan, Q.; Wang, X.-S. Nickel-catalyzed C–H trifluoromethylation of electron-rich heteroarenes. Adv. Synth. Catal.2016, 358, 3528–3533.10.1002/adsc.201600702Suche in Google Scholar

[25] Zhu, M.; Han, X.; Fu, W.; Wang, Z.; Ji, B.-M.; Hao,X.-Q.; Song, M.-P.; Xu, C. Regioselective 2,2,2-trifluoroethylation of imidazopyridines by visible light photoredox catalysis. J. Org. Chem.2016, 81, 7282–7287.10.1021/acs.joc.6b00950Suche in Google Scholar PubMed

[26] Fu, W.; Han, X.; Zhu, M.; Xu, C.; Wang, Z.; Ji, B.-M.; Hao,X.-Q.; Song, M.-P. Visible-light-mediated radical oxydifluoromethylation of olefinic amides for the synthesis of CF2H-containing heterocycles. Chem. Commun.2016, 52, 13413–13416.10.1039/C6CC07771DSuche in Google Scholar

[27] Fu, W.; Zhu, M.; Zou, G.; Xu, C.; Wang, Z.; Ji, B.-M. Visible-light-mediated radical aryldifluoroacetylation of alkynes with ethyl bromodifluoroacetate for the synthesis of 3-difluoroacetylated coumarins. J. Org. Chem.2015, 80, 4766–4770.10.1021/acs.joc.5b00305Suche in Google Scholar PubMed

[28] Fu, W.; Zhu, M.; Zou, G. Synthesis of 3,3-disubstituted oxindoles by organoselenium-induced radical cyclizations of N-arylacrylamides. Heterocycl. Commun.2015, 21, 9–12.10.1515/hc-2014-0195Suche in Google Scholar

Received: 2017-5-18
Accepted: 2017-5-22
Published Online: 2017-6-27
Published in Print: 2017-8-28

©2017 Walter de Gruyter GmbH, Berlin/Boston

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Heruntergeladen am 2.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hc-2017-0101/html?srsltid=AfmBOoqpNrOS9n7OZV73Rq60dv_zYvBLCi9jSGjK_UGm6aVWLX0C--5R
Button zum nach oben scrollen